Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down – Should You Sell?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS – Get Free Report)’s share price gapped down prior to trading on Friday. The stock had previously closed at $28.29, but opened at $26.14. Kestra Medical Technologies shares last traded at $27.4690, with a volume of 17,577 shares.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on KMTS shares. Piper Sandler reaffirmed an “overweight” rating on shares of Kestra Medical Technologies in a research report on Tuesday, September 15th. Weiss Ratings raised shares of Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, September 16th. Evercore assumed coverage on shares of Kestra Medical Technologies in a research note on Tuesday, October 20th. They set an “outperform” rating and a $34.00 target price for the company. Wall Street Zen downgraded Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research report on Sunday, November 8th. Finally, Royal Bank Of Canada set a $30.00 price target on Kestra Medical Technologies in a research note on Tuesday, September 15th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Kestra Medical Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $29.00.

View Our Latest Stock Report on KMTS

Kestra Medical Technologies Price Performance

The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of -9.41 and a beta of 0.45. The company has a current ratio of 4.69, a quick ratio of 4.69 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average price of $27.68 and a 200 day moving average price of $24.17.

Kestra Medical Technologies (NASDAQ:KMTS – Get Free Report) last issued its quarterly earnings results on Monday, September 14th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.61) by ($0.14). Kestra Medical Technologies had a negative return on equity of 63.83% and a negative net margin of 140.43%. The firm had revenue of $30.97 million for the quarter. As a group, equities research analysts expect that Kestra Medical Technologies, Ltd. will post -2.45 earnings per share for the current year.

Insider Activity at Kestra Medical Technologies

In other news, CFO Vaseem Mahboob sold 39,903 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $30.48, for a total value of $1,216,243.44. Following the transaction, the chief financial officer directly owned 60,609 shares in the company, valued at approximately $1,847,362.32. This represents a 39.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Conor Hanley sold 5,694 shares of the firm’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $25.25, for a total value of $143,773.50. Following the transaction, the director owned 6,272 shares of the company’s stock, valued at approximately $158,368. This represents a 47.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 251,456 shares of company stock valued at $7,173,746 over the last quarter. 5.30% of the stock is owned by insiders.

Hedge Funds Weigh In On Kestra Medical Technologies

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Sterling Capital Management LLC increased its holdings in shares of Kestra Medical Technologies by 834.0% in the 3rd quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock valued at $25,000 after acquiring an additional 784 shares during the period. Global Retirement Partners LLC increased its stake in Kestra Medical Technologies by 56,300.0% in the third quarter. Global Retirement Partners LLC now owns 1,692 shares of the company’s stock valued at $48,000 after purchasing an additional 1,689 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new position in Kestra Medical Technologies in the third quarter valued at $353,000. Pathstone Holdings LLC purchased a new position in shares of Kestra Medical Technologies during the third quarter worth about $356,000. Finally, Quantinno Capital Management LP purchased a new stake in Kestra Medical Technologies during the 1st quarter valued at approximately $431,000.

Kestra Medical Technologies Company Profile

(Get Free Report)

Kestra Medical Technologies is a medical technology company focused on wearable solutions for people at risk of sudden cardiac arrest. Its products combine cardiac monitoring, treatment technology and digital services intended to support patients and their care teams. The company’s flagship product, the ASSURE wearable cardioverter defibrillator, continuously monitors a patient’s heart rhythm and can deliver a treatment shock if it detects a life-threatening arrhythmia. The system also provides alerts and supports remote sharing of patient data with clinicians.

Recommended Stories

Receive News & Ratings for Kestra Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kestra Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.